HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- FDA guidance highlights inappropriate use of power morcellation, but concern about interpretation lingers
-
- ASCO statement on Medicaid reform reflects physicians’ professional responsibilities Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA grants fast track status to SGX301 for cutaneous T-cell lymphoma
- FDA grants orphan drug status to ovarian cancer treatment
- FDA grants fast track designation to CPX-351 for AML
- Women with breast cancer demonstrate elevated long-term risk for depression
- Weekly prophylaxis with nonacog beta pegol safe, effective for hemophilia B
- Carboplatin–paclitaxel combination shows promise for rare form of thymus cancer
- Aprepitant regimen reduced CINV in post-transplant myeloma
-
- IMRT reduced recurrence rates in primary soft tissue sarcoma
- Lenalidomide plus rituximab induced high response rate in untreated indolent lymphoma
- Observation most common adjuvant management for stage I testicular seminoma
- p16 expression predicted outcomes in non-OPSCC
- Malignant bowel obstruction palliative surgery linked to complications, mortality
- AACR, ASCO recommend regulation of e-cigarettes, other electronic nicotine delivery systems
- Active surveillance for small papillary thyroid cancers should be used with caution
- Adjuvant chemoradiotherapy may improve survival in head and neck Merkel cell carcinoma
-
- Ado-trastuzumab emtansine significantly extended OS in HER-2–positive breast cancer with CNS metastases
- ASCT regimen shows promise for CNS-involved non-Hodgkin’s lymphoma
- Bisphosphonate treatment did not reduce risk for postmenopausal breast cancer
- BRCA testing has 'clear role' for triple-negative breast cancer
- Children who remain leukemia-free 5 years after diagnosis considered cured
- Complete mesocolic excision for colon cancer yielded better DFS than conventional surgery
- Crizotinib superior to chemotherapy in advanced, ALK-positive NSCLC
- Early palliative care improved quality of life in patients with advanced-stage cancers
-
- Early referral to outpatient palliative care improved end-of-life care
- Exercise improved aromatase inhibitor-induced arthralgia in breast cancer survivors
- GTX effective neoadjuvant treatment in locally advanced pancreatic cancer
- High vitamin D levels associated with lower CRC risk, increased immune response
- Higher coffee consumption shows ties to decreased melanoma risk
- HPV testing recommended as primary screening option for cervical cancer
- IG-IMRT showed favorable outcomes in skull base chordoma, chondrosarcoma
- Ipilimumab plus fotemustine demonstrated long-term efficacy in metastatic melanoma
-
- Keratinization may be prognostic in certain head and neck cancers
- More studies urged in managing posttreatment fatigue in thyroid cancer
- Most blood clot treatments demonstrate similar efficacy, safety
- Nivolumab superior to dacarbazine for untreated metastatic melanoma
- Normal D-dimer levels after anticoagulant therapy may indicate lower recurrence of VTE
- Olaparib plus chemotherapy extended PFS in recurrent platinum-sensitive ovarian cancer
- Oral HPV16 infection persisted longer in older men
- Palbociclib plus letrozole doubled PFS in advanced HER-2-negative breast cancer
-
- PD-L1 expression, CD8+ T-cell counts associated with shorter OS in mRCC
- PET/CT may be new standard for response assessment in follicular lymphoma
- Philadelphia chromosome-like ALL demonstrates alterations potentially targetable by TKIs
- Prognostic POLE proofreading may reduce overtreatment of endometrial cancer
- Proton therapy, IMRT demonstrated similar toxicity profiles in prostate cancer
- Second-line SBRT plus erlotinib extended survival in advanced NSCLC
- Shorter therapy did not compromise outcomes in low-risk embryonal rhabdomyosarcoma
- Subcutaneous, IV trastuzumab similarly safe, effective for HER-2-positive early breast cancer
-
- Subset of patients less likely to develop subsequent keratinocyte carcinoma
- Addition of head, neck exam to lung cancer screening may increase early detection of HNSCC
- Thyroid cancer conditional survival affected by age, cancer stage, survivorship phase
- Time to diagnosis not associated with survival in adolescents with Ewing tumors
- Tumor size, location, grade predicted late recurrence in soft tissue sarcoma
- Vigilant surveillance for esophageal carcinoma relapse appropriate after bimodality therapy
- Age-related clonal hematopoiesis increased risk for hematologic malignancies
- Primary melanoma regression not linked to sentinel node status
-
- Cancer center names new deputy director
- Einstein, Montefiore appoint chair of gynecology
- Kimmel Cancer Center appoints director of thoracic oncology
- Medical Center appoints director of thoracic oncology immunotherapeutics
- Physicians named to NCI task forces
- Roswell Park Cancer Institute names chief of clinical services
- Lanreotide shows promise in patients with pancreatic neuroendocrine tumors
- Less-intensive regimen maintained efficacy, reduced toxicity in metastatic pancreatic cancer
-
- Panitumumab plus FOLFOX6 benefited patients with RAS wild-type metastatic colorectal cancer
- Some patients with rectal cancer may safely avoid surgery
- ASCO: CancerLinQ to provide 'big data' to improve patient care